No Data
No Data
We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate
Terns Pharma Analyst Ratings
$TERN Stock Is up 15% Today. Here's What We See in Our Data.
SA Asks: What's the Best Weight-loss Drug Stock Right Now?
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $14
Pfizer (PFE.US) facing setbacks in research sparks acquisition speculation, stocks of the new weight loss drug rising sharply.
Pfizer (PFE.US) has stopped the development of the highly anticipated oral weight loss drug Danuglipron. Investors are betting that this setback may prompt Pfizer to seek acquisition trades, leading to a rise in the stock prices of several biotechnology companies developing weight loss drugs on Monday.